Skip to main content
. 2022 May 29;2022:3485757. doi: 10.1155/2022/3485757

Table 3.

Pulmonary function tests and PEFR before and after herbal medicine treatments.

Total (n = 24) Asthma (n = 14) COPD (n = 10)
FVC
 Baseline 86.42 (78.08, 94.76) 88.00 (78.18, 97.82) 84.20 (67.13, 101.27)
 Week 12 86.72 (76.543, 96.89) 88.00 (76.75, 99.24) 84.93 (65.62, 104.23)
  p value 0.9326 0.9994 0.8227
FEV1
 Baseline 73.92 (64.26, 83.57) 79.93 (67.72, 92.14) 65.50 (48.63, 82.37)
 Week 12 71.61 (60.67, 82.55) 77.68 (64.08, 91.27) 63.11 (47.41, 78.80)
  p value 0.5987 0.7383 0.4743
FEV1/FVC
 Baseline 62.13 (56.32, 67.93) 67.29 (61.37, 73.21) 54.90 (44.00, 65.80)
 Week 12 60.30 (53.83, 66.77) 65.50 (57.98, 73.03) 53.02 (42.92, 63.12)
  p value 0.3256 0.5021 0.4523
PEFR
 Baseline 255.0 (209.7, 300.3) 286.4 (224.4, 348.5) 211.0 (143.1, 278.9)
 Week 4 254.0 (212.5, 295.5) 280.4 (219.3, 341.4) 217.0 (165.2, 268.8)
  p value 0.9424 0.7959 0.6327
 Week 8 263.0 (226.3, 299.8) 293.8 (243.7, 343.9) 220.0 (170.4, 269.6)
  p value 0.5750 0.7362 0.6099
 Week 12 256.2 (218.6, 293.9) 276.4 (220.4, 332.3) 228.1 (187.5, 268.7)
  p value 0.9305 0.6451 0.2201

Data are presented as mean (95% CI). p value by paired t-test.